FDA.reportPublic FDA data

Application 207612

Type
ANDA
Sponsor
NOVELGENIX THERAPS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001NAPROXEN SODIUMNAPROXEN SODIUMTABLET;ORAL220MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
46994-661NAPROXEN SODIUMNAPROXEN SODIUMSAVE-A-LOT FOOD STORES, LTD.ANDACurrent
46994-661NAPROXEN SODIUMNAPROXEN SODIUMSAVE-A-LOT FOOD STORES, LTD.ANDACurrent
46994-661NAPROXEN SODIUMNAPROXEN SODIUMSAVE-A-LOT FOOD STORES, LTD.ANDACurrent
50090-4704Naproxen sodiumNaproxen sodiumA-S Medication SolutionsANDACurrent
50090-4704Naproxen sodiumNaproxen sodiumA-S Medication SolutionsANDACurrent
68210-4120Naproxen SodiumNaproxen SodiumSpirit Pharmaceuticals LLCANDACurrent
68210-4121Naproxen SodiumNaproxen SodiumSpirit Pharmaceuticals LLCANDACurrent
68210-4137Naproxen SodiumNaproxen SodiumSpirit Pharmaceuticals LLCANDACurrent
68210-4137Naproxen SodiumNaproxen SodiumSpirit Pharmaceuticals LLCANDACurrent
68210-4137Naproxen SodiumNaproxen SodiumSpirit Pharmaceuticals LLCANDACurrent
68210-4137Naproxen SodiumNaproxen SodiumSpirit Pharmaceuticals LLCANDACurrent
68210-4137Naproxen SodiumNaproxen SodiumSpirit Pharmaceuticals LLCANDACurrent
69230-313Naproxen sodiumNaproxen sodiumCamber Consumer CareANDACurrent
72090-003Pain and Fever ReliefNaproxen SodiumPioneer Life Sciences, LLCANDACurrent